SynthesisZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2026
[Fine-needle aspiration cytology and fine-needle aspirate calci-tonin measurement for diagnosing medullary thyroid carci-noma: a meta-analysis].
Synthesis in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo systematically evaluate the diagnostic value of fine-needle aspiration cytology (FNAC) and fine-needle aspirate calcitonin (FNA-CT) measurement in medullary thyroid carcinoma (MTC). This study has been registered in the International Prospective Register of Systematic Reviews (PROSPERO, CRD420251243288) and was conducted and reported in accordance with the Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies (PRISMA-DTA) 2018.
methodsRelevant studies evaluating FNAC and FNA-CT for the diagnosis of MTC were systematically searched in Chinese and English databases from January 1, 1995 to December 31, 2024. The methodological quality of the included studies was assessed using the QUADAS-2, and meta-analysis was performed using Stata 16.0. The threshold effect was evaluated using the Spearman correlation test, and heterogeneity was assessed using Cochran's Q test and the
resultsA total of 13 studies involving 937 patients with 444 MTC lesions were finally included. The Spearman correlation test showed no obvious threshold effect for FNAC in diagnosing MTC, whereas a potential threshold effect was observed for FNA-CT. Heterogeneity analysis revealed varying degrees of heterogeneity across the diagnostic performance indicators of both FNAC and FNA-CT; therefore, random-effects models were used for pooled analysis. For FNAC, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.56 (95%CI: 0.51-0.61), 0.98 (95%CI: 0.94-1.00), 34.25 (95%CI: 8.98-130.62), 0.45 (95%CI: 0.39-0.51), and 76.97 (95%CI: 18.72-316.52), respectively. For FNA-CT, the corresponding values were 0.98 (95%CI: 0.94-0.99), 0.97 (95%CI: 0.94-0.99), 37.42 (95%CI: 16.91-82.80), 0.02 (95%CI: 0.01-0.06), and 1891.55 (95%CI: 351.09-10 191.13), respectively. The SROC AUCs of FNAC and FNA-CT for diagnosing MTC were 0.65 and 1.00, respectively. Meta-regression analysis suggested that the heterogeneity of FNAC might be related to study design and detection method, whereas no significant source of heterogeneity was identified for FNA-CT. Possible publication bias was detected for both methods. Both Fagan nomogram analysis and likelihood ratio scattergram analysis showed that FNA-CT had high clinical value for both confirming and excluding MTC, whereas FNAC had good value for confirming MTC but limited value for excluding it.
conclusionsFNA-CT demonstrates high diagnostic value for MTC, with overall diagnostic efficacy superior to that of FNAC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.